Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

359 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study.
Holdaas H, Fellström B, Cole E, Nyberg G, Olsson AG, Pedersen TR, Madsen S, Grönhagen-Riska C, Neumayer HH, Maes B, Ambühl P, Hartmann A, Staffler B, Jardine AG; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators. Holdaas H, et al. Among authors: nyberg g. Am J Transplant. 2005 Dec;5(12):2929-36. doi: 10.1111/j.1600-6143.2005.01105.x. Am J Transplant. 2005. PMID: 16303007 Clinical Trial.
Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.
Holdaas H, Fellström B, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Logan JO, Staffler B, Gimpelewicz C; ALERT Study Group. Holdaas H, et al. Among authors: nyberg g. Nephrol Dial Transplant. 2005 May;20(5):974-80. doi: 10.1093/ndt/gfh735. Epub 2005 Mar 22. Nephrol Dial Transplant. 2005. PMID: 15784644 Clinical Trial.
Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial.
Fellström B, Holdaas H, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Logan JO, Pedersen TR; Assessment of Lescol in Renal Transplantation Study Investigators. Fellström B, et al. Among authors: nyberg g. Kidney Int. 2004 Oct;66(4):1549-55. doi: 10.1111/j.1523-1755.2004.00919.x. Kidney Int. 2004. PMID: 15458450 Clinical Trial.
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.
Holdaas H, Fellström B, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators. Holdaas H, et al. Among authors: nyberg g. Lancet. 2003 Jun 14;361(9374):2024-31. doi: 10.1016/S0140-6736(03)13638-0. Lancet. 2003. PMID: 12814712 Clinical Trial.
fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study.
Jardine AG, Holdaas H, Fellström B, Cole E, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Maes B, Ambühl P, Olsson AG, Holme I, Fauchald P, Gimpelwicz C, Pedersen TR; ALERT Study Investigators. Jardine AG, et al. Among authors: nyberg g. Am J Transplant. 2004 Jun;4(6):988-95. doi: 10.1111/j.1600-6143.2004.00445.x. Am J Transplant. 2004. PMID: 15147434 Clinical Trial.
Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial.
Fellström B, Holdaas H, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Staffler B, Pedersen TR; Assessment of Lescol in Renal Transplantation Study Investigators. Fellström B, et al. Among authors: nyberg g. Transplantation. 2005 Jan 27;79(2):205-12. doi: 10.1097/01.tp.0000147338.34323.12. Transplantation. 2005. PMID: 15665769 Clinical Trial.
359 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page